INNATE PHARMA S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 8128
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902936 PAN-KIR2DL NK-receptor antibodies and their use in diagnostics and therapyJul 01, 04Feb 27, 18[A61K, C12N, G01N, C07K]
9844593 Methods for treatment of recurrent hematological malignanciesNov 22, 11Dec 19, 17[A61K, C07K]
9447185 Compositions and methods for treating proliferative disordersOct 13, 06Sep 20, 16[A61K, C07K]
9090876 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compoundsJul 30, 10Jul 28, 15[A61K, C12N, C07K]
9067997 Anti-KIR antibodies for the treatment of inflammatory and autoimmune disordersMay 25, 12Jun 30, 15[A61K, C07K]
8993319 Monoclonal antibodies against NKG2ADec 27, 05Mar 31, 15[A61K, C12N, C07K]
8637258 Compositions and methods for regulating NK cell activityJun 10, 10Jan 28, 14[C12P, G01N, C07K]
8465931 Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptorMay 07, 10Jun 18, 13[G01N]
7932055 Soluble heterodimeric CD94/NKG2 receptors fusion proteinsJun 22, 07Apr 26, 11[C12P, C07K]
7803376 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compoundsJul 23, 04Sep 28, 10[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0132,316 MONOCLONAL ANTIBODIES AGAINST NKG2AAbandonedJan 12, 15May 14, 15[G01N, C07K]
2014/0234,342 NKP46-MEDIATED NK CELL TUNINGAbandonedJun 21, 12Aug 21, 14[C07K]
2011/0229,486 Monoclonal Antibodies Against NKG2AAbandonedFeb 28, 11Sep 22, 11[A61K, A61P, C07K]
8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activityExpiredJan 14, 10Sep 13, 11[A61K]
2011/0185,441 TRANSGENIC ANIMALS AND METHODS OF MAKING RECOMBINANT ANTIBODIESAbandonedApr 08, 11Jul 28, 11[A01K]
2011/0076,296 TLR3 Agonist CompositionsAbandonedApr 22, 09Mar 31, 11[A61K, C12N, G01N, A61P]
2010/0254,940 Compositions and Methods for Regulating an Immune Response in a SubjectAbandonedJun 28, 10Oct 07, 10[A61K, A61P]
2010/0222,306 Class of Gamma Delta T Cells Activators and Use ThereofAbandonedMar 22, 10Sep 02, 10[A61K, C07F, A61P]
7767842 Class of γδ T cells activators and use thereofExpiredDec 02, 04Aug 03, 10[A61K, C07F]
2010/0189,681 Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of CancerAbandonedMay 21, 08Jul 29, 10[A61K, A61P]
2010/0124,555 Compositions and Methods for Treating Pancreatic TumorsAbandonedNov 05, 09May 20, 10[A61K, C12N, G01N, A61P, C07K]
7683045 Class of γδ T cells activators and use thereofExpiredMar 21, 06Mar 23, 10[A61K, C07F]
2010/0029,674 Methods of Using Phosphoantigen for the Treatment of CancerAbandonedNov 16, 07Feb 04, 10[A61K, C12N]
2010/0015,153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the SameAbandonedFeb 25, 09Jan 21, 10[A61K, C12Q, C12N, G01N]
2009/0304,688 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell ActivatorsAbandonedJul 12, 07Dec 10, 09[A61K, A61P]
2008/0248,045 POLYPEPTIDES HAVING A TRIGGERING NK ACTIVITY AND BIOLOGICAL APPLICATIONSAbandonedSep 26, 07Oct 09, 08[A61K, C07H, C12Q, C12N, A61P, C07K]
2008/0196,111 Expression Vectors and Methods for Obtaining Nk Cell Specific ExpressionAbandonedMar 17, 06Aug 14, 08[C12Q, C12N, A01K]
2008/0196,112 Transgenic Animals and Methods of Making Recombinant AntibodiesAbandonedApr 28, 06Aug 14, 08[C12Q, C12P, C12N, A01K]
2008/0063,717 Pharmaceutical Compositions Having an Effect on the Proliferation of Nk Cells and a Method Using the SameAbandonedDec 22, 03Mar 13, 08[A61K, A61P]
2007/0231,322 Compositions and Methods for Treating Proliferative Disorders Such as Nk-Type LdglAbandonedApr 29, 05Oct 04, 07[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.